Post job

Acadia Pharmaceuticals CEO and executives

Executive Summary. Based on our data team's research, Stephen R. Davis is the Acadia Pharmaceuticals's CEO. Acadia Pharmaceuticals has 570 employees, of which 44 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Acadia Pharmaceuticals executive team is 36% female and 64% male.
  • 59% of the management team is White.
  • 12% of Acadia Pharmaceuticals management is Hispanic or Latino.
  • 9% of the management team is Black or African American.
Work at Acadia Pharmaceuticals?
Share your experience

Rate Acadia Pharmaceuticals' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Stephen R. Davis

CEO

Stephen R. Davis's LinkedIn

Stephen R. Davis is a Chief Executive Officer & Board Member at ACADIA PHARMACEUTICALS INC.

Laura A. Brege

Board Member

Laura A. Brege's LinkedIn

Ponni Subbiah M.d.

Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer

Ponni Subbiah M.d.'s LinkedIn

Dr. Subbiah is responsible for corporate medical affairs including medical strategy, scientific communications, and medical science liaison activities.

Dr. Subbiah is a neurologist with over 20 years of experience in the pharmaceutical industry and global health sector. She has led the development and execution of medical and clinical research strategies in various therapeutic areas, including neurology, psychiatry, opioid addiction, pain, oncology, diabetes, urology, inflammation, respiratory, and infectious diseases.

Dr. Subbiah was most recently Chief Medical Officer for Indivior Inc., with responsibility for pharmacovigilance and medical affairs globally. She was also the company spokesperson at policy discussions including testifying at the Presidential Commission on Combating Drug Addiction and Opioid Crisis and the hearing by the House Committee on Energy & Commerce on the opioid crisis. During her previous tenure of over 15 years at Pfizer, Inc., she held various leadership roles in global medical affairs and led Pfizer’s Global Access program to improve healthcare access for low-income populations in the developing world through approaches that were commercially viable and sustainable.

Stephen R. Biggar

Chairman

Acadia Pharmaceuticals

Board Member

Acadia Pharmaceuticals's LinkedIn

Austin D. Kim

Executive Vice President, General Counsel and Secretary

Austin D. Kim's LinkedIn

Brendan P. Teehan

Chief Operating Officer, EVP & Head-Commercial

Brendan P. Teehan's LinkedIn

Julian Charles Baker

Board Member

Amanda Morgan

Senior Vice President Sales and Market Access, VP

Amanda Morgan's LinkedIn

Amanda Morgan is a SVP, Chief Revenue and Customer Officer at ACADIA PHARMACEUTICALS INC.

Bob Mischler

SVP Strategy and Technology Operations, VP

Bob Mischler's LinkedIn

Do you work at Acadia Pharmaceuticals?

Does the leadership team provide a clear direction for Acadia Pharmaceuticals?

Acadia Pharmaceuticals jobs

Acadia Pharmaceuticals board members

Name & TitleBio
Stephen R. Davis

CEO

Stephen R. Davis's LinkedIn

Stephen R. Davis is a Chief Executive Officer & Board Member at ACADIA PHARMACEUTICALS INC.

Laura A. Brege

Board Member

Laura A. Brege's LinkedIn

Stephen R. Biggar

Chairman

Acadia Pharmaceuticals

Board Member

Acadia Pharmaceuticals's LinkedIn

Julian Charles Baker

Board Member

Daniel B. Soland

Board Member

Edmund P. Harrigan

Board Member

Edmund P. Harrigan's LinkedIn

James M. Daly

Board Member

Acadia Pharmaceuticals Inc

Board Member

Acadia Pharmaceuticals Inc's LinkedIn

Elizabeth A Garofalo

Board Member

Acadia Pharmaceuticals leadership demographics

Acadia Pharmaceuticals gender distribution in management team

  • The Acadia Pharmaceuticals executive team is 36% female and 64% male.
  • Acadia Pharmaceuticals is 52% female and 48% male company-wide.
Male
Male
64%
Company-wide: 48%
Female
Female
36%
Company-wide: 52%

Acadia Pharmaceuticals executives by race

Management Team:
  • The most common ethnicity among Acadia Pharmaceuticals executive officers is White.
  • 59% of the management team is White.
  • 16% of Acadia Pharmaceuticals's management is Asian.
  • 12% of the management team is Hispanic or Latino.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 52% of employees are White.
  • 28% of employees are Hispanic or Latino.
  • 8% of employees are Asian.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Acadia Pharmaceuticals jobs nearby

Acadia Pharmaceuticals executives FAQs

Zippia gives an in-depth look into the details of Acadia Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Acadia Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Acadia Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Acadia Pharmaceuticals. The data presented on this page does not represent the view of Acadia Pharmaceuticals and its employees or that of Zippia.

Acadia Pharmaceuticals may also be known as or be related to ACADIA PHARMACEUTICALS INC, ACADIA Pharmaceuticals Inc, ACADIA Pharmaceuticals Inc., Acadia Pharmaceuticals, Acadia Pharmaceuticals Inc. and Receptor Technologies.